A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

SIMPLE SUMMARY: This prospective phase II trial evaluated the safety and efficacy of direct oral anticoagulants (DOACs) versus subcutaneous dalteparin for cancer-associated venous thromboembolism (CA-VTE) in patients with high-risk cancer types and currently active advanced cancers. The clinically r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jwa Hoon, Yoo, Changhoon, Seo, Seyoung, Jeong, Jae Ho, Ryoo, Baek-Yeol, Kim, Kyu-pyo, Lee, Jung Bok, Lee, Keun-Wook, Kim, Ji-Won, Kim, Il-Hwan, Kang, Myoungjoo, Ryu, Hyewon, Cheon, Jaekyung, Park, Sook Ryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833795/
https://www.ncbi.nlm.nih.gov/pubmed/35158827
http://dx.doi.org/10.3390/cancers14030559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833795/
https://www.ncbi.nlm.nih.gov/pubmed/35158827
http://dx.doi.org/10.3390/cancers14030559

Ejemplares similares